Because testing for ANA is frequently performed unnecessarily by clinicians in patients presenting with symptoms such as widespread pain and fatigue, the American Society for Clinical Pathology and American Society for Clinical Laboratory Science recommended preserving the test for patients, with a high pre-test probability for connective tissue disease [11], as a positive result can be present in a healthy subject. Here, BTG3 is linked to connective tissue disorder.